Cubist Systematic Strategies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,329
| Closed | -$766K | – | 3236 |
|
|
2021
Q1 | $766K | Buy |
+20,329
| New | +$766K | 0.01% | 1701 |
|
|
2020
Q1 | – | Sell |
-22,818
| Closed | -$105K | – | 2607 |
|
|
2019
Q4 | $105K | Buy |
22,818
+11,764
| +106% | +$54.1K | ﹤0.01% | 2182 |
|
|
2019
Q3 | $43K | Sell |
11,054
-50,610
| -82% | -$197K | ﹤0.01% | 2071 |
|
|
2019
Q2 | $372K | Buy |
61,664
+50,821
| +469% | +$307K | 0.01% | 1668 |
|
|
2019
Q1 | $145K | Sell |
10,843
-27,308
| -72% | -$365K | ﹤0.01% | 1914 |
|
|
2018
Q4 | $355K | Buy |
+38,151
| New | +$355K | 0.02% | 1166 |
|
|
2018
Q2 | – | Sell |
-11,163
| Closed | -$192K | – | 2154 |
|
|
2018
Q1 | $192K | Buy |
11,163
+1,355
| +14% | +$23.3K | 0.01% | 1421 |
|
|
2017
Q4 | $215K | Buy |
9,808
+9,060
| +1,211% | +$199K | 0.01% | 1485 |
|
|
2017
Q3 | $31K | Buy |
+748
| New | +$31K | ﹤0.01% | 1758 |
|
|
2017
Q2 | – | Sell |
-3,111
| Closed | -$112K | – | 1956 |
|
|
2017
Q1 | $112K | Buy |
+3,111
| New | +$112K | 0.01% | 1368 |
|
|
2016
Q4 | – | Sell |
-7,142
| Closed | -$375K | – | 1961 |
|
|
2016
Q3 | $375K | Buy |
7,142
+2,811
| +65% | +$148K | 0.02% | 872 |
|
|
2016
Q2 | $179K | Sell |
4,331
-4,041
| -48% | -$167K | 0.01% | 1371 |
|
|
2016
Q1 | $340K | Buy |
8,372
+3,487
| +71% | +$142K | 0.02% | 927 |
|
|
2015
Q4 | $203K | Buy |
4,885
+3,274
| +203% | +$136K | 0.01% | 1348 |
|
|
2015
Q3 | $25K | Sell |
1,611
-1,189
| -42% | -$18.5K | ﹤0.01% | 1769 |
|
|
2015
Q2 | $70K | Buy |
+2,800
| New | +$70K | ﹤0.01% | 1671 |
|
|
2015
Q1 | – | Sell |
-9,647
| Closed | -$260K | – | 2158 |
|
|
2014
Q4 | $260K | Buy |
+9,647
| New | +$260K | 0.01% | 1326 |
|